125 related articles for article (PubMed ID: 26844697)
1. ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.
Yang S; Zhou L; Reilly PT; Shen SM; He P; Zhu XN; Li CX; Wang LS; Mak TW; Chen GQ; Yu Y
Cell Death Dis; 2016 Feb; 7(2):e2082. PubMed ID: 26844697
[TBL] [Abstract][Full Text] [Related]
2. BALB/c-congenic ANP32B-deficient mice reveal a modifying locus that determines viability.
Leo VI; Bunte RM; Reilly PT
Exp Anim; 2016; 65(1):53-62. PubMed ID: 26558540
[TBL] [Abstract][Full Text] [Related]
3. Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.
Reilly PT; Afzal S; Gorrini C; Lui K; Bukhman YV; Wakeham A; Haight J; Ling TW; Cheung CC; Elia AJ; Turner PV; Mak TW
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10243-8. PubMed ID: 21636789
[TBL] [Abstract][Full Text] [Related]
4. ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
Yang Q; Liu HR; Yang S; Wei YS; Zhu XN; Zhi Z; Zhu D; Chen GQ; Yu Y
Cancer Sci; 2023 Jul; 114(7):2882-2894. PubMed ID: 37137487
[TBL] [Abstract][Full Text] [Related]
5. ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.
Yang S; Zhu XN; Zhang HL; Yang Q; Wei YS; Zhu D; Liu MD; Shen SM; Xia L; He P; Ge MK; Pan YL; Zhao M; Wu YL; Zheng JK; Chen GQ; Yu Y
Blood; 2021 Dec; 138(24):2485-2498. PubMed ID: 34359074
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.
Li CX; Shen SM; Wang LS; Yu Y
Mol Med Rep; 2015 Apr; 11(4):2813-8. PubMed ID: 25483709
[TBL] [Abstract][Full Text] [Related]
7. ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling.
Zhou C; Ma H; Yu W; Zhou Y; Zhang X; Meng Y; Chen C; Zhang J; Shi G
Biochem Biophys Res Commun; 2024 Feb; 698():149543. PubMed ID: 38266312
[TBL] [Abstract][Full Text] [Related]
8. Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) contributes to retinoic acid-induced differentiation of leukemic cells.
Yu Y; Shen SM; Zhang FF; Wu ZX; Han B; Wang LS
Biochem Biophys Res Commun; 2012 Jul; 423(4):721-5. PubMed ID: 22705300
[TBL] [Abstract][Full Text] [Related]
9. The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice.
Chemnitz J; Pieper D; Stich L; Schumacher U; Balabanov S; Spohn M; Grundhoff A; Steinkasserer A; Hauber J; Zinser E
Sci Rep; 2019 Mar; 9(1):4853. PubMed ID: 30890743
[TBL] [Abstract][Full Text] [Related]
10. ANP32B Deficiency Protects Mice From Lethal Influenza A Virus Challenge by Dampening the Host Immune Response.
Beck S; Zickler M; Pinho Dos Reis V; Günther T; Grundhoff A; Reilly PT; Mak TW; Stanelle-Bertram S; Gabriel G
Front Immunol; 2020; 11():450. PubMed ID: 32231671
[TBL] [Abstract][Full Text] [Related]
11. ANP32B promotes lung cancer progression by regulating VDAC1.
Li T; Wang N; Li S; Yan H; Gao S; Gao W; Xu R
Gene; 2023 Apr; 859():147200. PubMed ID: 36642319
[TBL] [Abstract][Full Text] [Related]
12. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
[TBL] [Abstract][Full Text] [Related]
13. Acidic Leucine-Rich Nuclear Protein Phosphatase 32B Promotes Prostate Adenocarcinoma Cell Progression by Regulating Apoptosis and Epithelial-Mesenchymal Transition.
A M; Wang L; Xue Y; Wang C
Altern Ther Health Med; 2024 Feb; ():. PubMed ID: 38401083
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells.
Shen SM; Yu Y; Wu YL; Cheng JK; Wang LS; Chen GQ
Carcinogenesis; 2010 Mar; 31(3):419-26. PubMed ID: 20015864
[TBL] [Abstract][Full Text] [Related]
15. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
17. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
18. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
19. ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1.
Yang LL; Li M; Huang W; Ren PT; Yan QH; Hao YH
Heliyon; 2024 Jan; 10(1):e23829. PubMed ID: 38192816
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.
Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z
Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
